Headlines pertaining to Gilead’s coronavirus treatment, Remdesivir, cause investors to reverse course on Thursday, leaving broad market gauges stalled around their declining 50-day moving averages. https://t.co/sfz8YPJlz3 $GILD $SPX $SPY $ES_F https://t.co/qiyvDlisnQ